Medtronic Resolute Onyx DES Drug-eluting Stent

Resolute Onyx™ is a drug-eluting stent (DES) that's different by design, optimised for complex PCI, and proven safe and effective in real-world, high bleeding risk patients on 1-month dual antiplatelet therapy (DAPT). Resolute Onyx drug-eluting stent (DES) offers flexibility, conformability, a 2.0-5.0 mm size matrix, and is indicated for high bleeding risk patients and labeled for one-month DAPT. Cardiology Stent Medtronic RONYX22515UX Resolute Onyx DES Drug-eluting Stent (SD 2.25) Cardiology Stent Medtronic RONYX22518UX Resolute Onyx DES Drug-eluting Stent (SD 2.25) Cardiology Stent Medtronic RONYX22522UX Resolute Onyx DES Drug-eluting Stent (SD 2.25) Cardiology Stent Medtronic RONYX27515W Resolute Onyx DES Drug-eluting Stent (SD 2.75) Cardiology Stent Medtronic RONYX27518W Resolute Onyx DES Drug-eluting Stent (SD 2.75) Cardiology Stent Medtronic RONYX30015W Resolute Onyx DES Drug-eluting Stent (SD 3.00) Cardiology Stent Medtronic RONYX30018W Resolute Onyx DES Drug-eluting Stent (SD 3.00) Cardiology Stent Medtronic RONYX35015W Resolute Onyx DES Drug-eluting Stent (SD 3.50) Cardiology Stent Medtronic RONYX35022W Resolute Onyx DES Drug-eluting Stent (SD 3.50) About the Company Legal Status of Firm: Limited Company Number of Employees: 11 To 25 People Annual Turnover: 5 - 25 Cr company-description: Saaskin Corporation is a fully integrated Technology based company with excellent infrastructure that includes Manufacturing, Distribution and Consulting of specific range of Technology Products and Services that meets international standards. Saaskin has three Business Units namely Manufacture, Wholesaler, Exporter, Importer and Trader. We are gradually grown over the years from a small workshop and now have manufacturing facilities that covers a total area of 28,000 Sq. Ft and Warehouse distribution facility of 8000 Sq. Ft.